BMY CapEx to Revenue

Bristol Myers Squibb · CapEx to Revenue

BMY logo

BMY CapEx to Revenue

Current (TTM)2.73%
BMY CapEx/Revenue (0.00% → 2.73%)
High-resolution chart · PNG

BMY capex to revenue history

Annual fiscal periods. Dates are reporting period ends; fiscal years can differ from calendar years.

Bristol Myers Squibb CapEx to Revenue — Annual fiscal periods
Period endingCapEx to Revenue
2.7202%
2.5839%
2.6863%
2.4221%
2.0977%
1.771%
3.1976%
4.2152%
5.078%
6.2542%
4.9517%
3.3126%
3.2774%
3.1099%
1.7275%
2.1761%
3.8813%
4.5686%
4.357%
4.4267%
3.9985%
4.1744%
4.7382%
6.5235%
5.267%
3.2334%
3.5061%
4.3098%
4.5925%
3.9894%
3.7263%
4.7814%
4.9943%
5.7996%
5.6277%
4.9806%
6.0398%
0%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.